Magnetar Financial’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AUPH
Magnetar Financial's AUPH Position: Q3 2026 in Review
Magnetar Financial sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2026, closing a stake of 11,739 shares — an estimated $199K sold.
Magnetar Financial first reported a position in AUPH in Q3 2025 and held it in 4 quarters. The position peaked at $1M in Q1 2026. 277 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.
- Magnetar Financial reported no remaining Aurinia Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Magnetar Financial sold 11,739 Aurinia Pharmaceuticals shares in Q3 2026, an estimated $199K.
- Magnetar Financial first reported a position in Aurinia Pharmaceuticals in Q3 2025 and held it in 4 quarters.
- Magnetar Financial's Aurinia Pharmaceuticals position peaked at $1M in Q1 2026.
- 277 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.
Based on Magnetar Financial's 13F filing for Q3 2026, filed 13 Nov 2026.